BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32764609)

  • 1. An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk.
    Wu L; Yang Y; Guo X; Shu XO; Cai Q; Shu X; Li B; Tao R; Wu C; Nikas JB; Sun Y; Zhu J; Roobol MJ; Giles GG; Brenner H; John EM; Clements J; Grindedal EM; Park JY; Stanford JL; Kote-Jarai Z; Haiman CA; Eeles RA; Zheng W; Long J; ; ; ; ;
    Nat Commun; 2020 Aug; 11(1):3905. PubMed ID: 32764609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A transcriptome-wide association study identifies novel candidate susceptibility genes for prostate cancer risk.
    Liu D; Zhu J; Zhou D; Nikas EG; Mitanis NT; Sun Y; Wu C; Mancuso N; Cox NJ; Wang L; Freedland SJ; Haiman CA; Gamazon ER; Nikas JB; Wu L
    Int J Cancer; 2022 Jan; 150(1):80-90. PubMed ID: 34520569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation and cis-regulation of gene expression by prostate cancer risk SNPs.
    Dai JY; Wang X; Wang B; Sun W; Jordahl KM; Kolb S; Nyame YA; Wright JL; Ostrander EA; Feng Z; Stanford JL
    PLoS Genet; 2020 Mar; 16(3):e1008667. PubMed ID: 32226005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative multi-omic analysis identifies genetically influenced DNA methylation biomarkers for breast and prostate cancers.
    Sathyanarayanan A; Tanha HM; Mehta D; Nyholt DR
    Commun Biol; 2022 Jun; 5(1):594. PubMed ID: 35710732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel role of prostate cancer risk variant rs7247241 on PPP1R14A isoform transition through allelic TF binding and CpG methylation.
    Tian Y; Soupir A; Liu Q; Wu L; Huang CC; Park JY; Wang L
    Hum Mol Genet; 2022 May; 31(10):1610-1621. PubMed ID: 34849858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine-mapping the 2q37 and 17q11.2-q22 loci for novel genes and sequence variants associated with a genetic predisposition to prostate cancer.
    Laitinen VH; Rantapero T; Fischer D; Vuorinen EM; Tammela TL; ; Wahlfors T; Schleutker J
    Int J Cancer; 2015 May; 136(10):2316-27. PubMed ID: 25335771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SLCO4C1 promoter methylation is a potential biomarker for prognosis associated with biochemical recurrence-free survival after radical prostatectomy.
    Li X; Zhang W; Song J; Zhang X; Ran L; He Y
    Clin Epigenetics; 2019 Jul; 11(1):99. PubMed ID: 31288850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genome-wide association study of prostate cancer in Latinos.
    Du Z; Hopp H; Ingles SA; Huff C; Sheng X; Weaver B; Stern M; Hoffmann TJ; John EM; Van Den Eeden SK; Strom S; Leach RJ; Thompson IM; Witte JS; Conti DV; Haiman CA
    Int J Cancer; 2020 Apr; 146(7):1819-1826. PubMed ID: 31226226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically Predicted Levels of DNA Methylation Biomarkers and Breast Cancer Risk: Data From 228 951 Women of European Descent.
    Yang Y; Wu L; Shu XO; Cai Q; Shu X; Li B; Guo X; Ye F; Michailidou K; Bolla MK; Wang Q; Dennis J; Andrulis IL; Brenner H; Chenevix-Trench G; Campa D; Castelao JE; Gago-Dominguez M; Dörk T; Hollestelle A; Lophatananon A; Muir K; Neuhausen SL; Olsson H; Sandler DP; Simard J; Kraft P; Pharoah PDP; Easton DF; Zheng W; Long J
    J Natl Cancer Inst; 2020 Mar; 112(3):295-304. PubMed ID: 31143935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk.
    Yang Y; Wu L; Shu X; Lu Y; Shu XO; Cai Q; Beeghly-Fadiel A; Li B; Ye F; Berchuck A; Anton-Culver H; Banerjee S; Benitez J; Bjørge L; Brenton JD; Butzow R; Campbell IG; Chang-Claude J; Chen K; Cook LS; Cramer DW; deFazio A; Dennis J; Doherty JA; Dörk T; Eccles DM; Edwards DV; Fasching PA; Fortner RT; Gayther SA; Giles GG; Glasspool RM; Goode EL; Goodman MT; Gronwald J; Harris HR; Heitz F; Hildebrandt MA; Høgdall E; Høgdall CK; Huntsman DG; Kar SP; Karlan BY; Kelemen LE; Kiemeney LA; Kjaer SK; Koushik A; Lambrechts D; Le ND; Levine DA; Massuger LF; Matsuo K; May T; McNeish IA; Menon U; Modugno F; Monteiro AN; Moorman PG; Moysich KB; Ness RB; Nevanlinna H; Olsson H; Onland-Moret NC; Park SK; Paul J; Pearce CL; Pejovic T; Phelan CM; Pike MC; Ramus SJ; Riboli E; Rodriguez-Antona C; Romieu I; Sandler DP; Schildkraut JM; Setiawan VW; Shan K; Siddiqui N; Sieh W; Stampfer MJ; Sutphen R; Swerdlow AJ; Szafron LM; Teo SH; Tworoger SS; Tyrer JP; Webb PM; Wentzensen N; White E; Willett WC; Wolk A; Woo YL; Wu AH; Yan L; Yannoukakos D; Chenevix-Trench G; Sellers TA; Pharoah PDP; Zheng W; Long J
    Cancer Res; 2019 Feb; 79(3):505-517. PubMed ID: 30559148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
    Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
    BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genome-wide analysis of DNA methylation in prostate cancer using the technology of Infinium HumanMethylation450 BeadChip (HM450)].
    Babalyan KA; Sultanov R; Generozov EV; Zakharzhevskaya NB; Sharova EI; Peshkov MN; Vasilev AO; Govorov AV; Pushkar DY; Prilepskaya EA; Danilenko SA; Babikova EA; Larin AK; Govorun VM
    Vopr Onkol; 2016; 62(1):122-32. PubMed ID: 30444590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-Wide Measures of Peripheral Blood Dna Methylation and Prostate Cancer Risk in a Prospective Nested Case-Control Study.
    FitzGerald LM; Naeem H; Makalic E; Schmidt DF; Dowty JG; Joo JE; Jung CH; Bassett JK; Dugue PA; Chung J; Lonie A; Milne RL; Wong EM; Hopper JL; English DR; Severi G; Baglietto L; Pedersen J; Giles GG; Southey MC
    Prostate; 2017 Apr; 77(5):471-478. PubMed ID: 28116812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence.
    Horning AM; Awe JA; Wang CM; Liu J; Lai Z; Wang VY; Jadhav RR; Louie AD; Lin CL; Kroczak T; Chen Y; Jin VX; Abboud-Werner SL; Leach RJ; Hernandez J; Thompson IM; Saranchuk J; Drachenberg D; Chen CL; Mai S; Huang TH
    Prostate; 2015 Nov; 75(15):1790-801. PubMed ID: 26332453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia.
    Devaney JM; Wang S; Funda S; Long J; Taghipour DJ; Tbaishat R; Furbert-Harris P; Ittmann M; Kwabi-Addo B
    Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):292-300. PubMed ID: 23896626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating Genome and Methylome Data to Identify Candidate DNA Methylation Biomarkers for Pancreatic Cancer Risk.
    Zhu J; Yang Y; Kisiel JB; Mahoney DW; Michaud DS; Guo X; Taylor WR; Shu XO; Shu X; Liu D; Li B; Tao R; Cai Q; Zheng W; Long J; Wu L
    Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2079-2087. PubMed ID: 34497089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic and integrative cross-omics analyses of cerebral white matter hyperintensities on MRI.
    Yang Y; Knol MJ; Wang R; Mishra A; Liu D; Luciano M; Teumer A; Armstrong N; Bis JC; Jhun MA; Li S; Adams HHH; Aziz NA; Bastin ME; Bourgey M; Brody JA; Frenzel S; Gottesman RF; Hosten N; Hou L; Kardia SLR; Lohner V; Marquis P; Maniega SM; Satizabal CL; Sorond FA; Valdés Hernández MC; van Duijn CM; Vernooij MW; Wittfeld K; Yang Q; Zhao W; Boerwinkle E; Levy D; Deary IJ; Jiang J; Mather KA; Mosley TH; Psaty BM; Sachdev PS; Smith JA; Sotoodehnia N; DeCarli CS; Breteler MMB; Ikram MA; Grabe HJ; Wardlaw J; Longstreth WT; Launer LJ; Seshadri S; Debette S; Fornage M
    Brain; 2023 Feb; 146(2):492-506. PubMed ID: 35943854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Genomic Impact of DNA CpG Methylation on Gene Expression; Relationships in Prostate Cancer.
    Long MD; Smiraglia DJ; Campbell MJ
    Biomolecules; 2017 Feb; 7(1):. PubMed ID: 28216563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling.
    Chung W; Kwabi-Addo B; Ittmann M; Jelinek J; Shen L; Yu Y; Issa JP
    PLoS One; 2008 Apr; 3(4):e2079. PubMed ID: 18446232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenome-Wide Association Study of Prostate Cancer in African Americans Identifies DNA Methylation Biomarkers for Aggressive Disease.
    Xu Y; Tsai CW; Chang WS; Han Y; Huang M; Pettaway CA; Bau DT; Gu J
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.